囊性纤维化患者对乙酰氨基酚过量后早期乙酰半胱氨酸治疗仍发生肝毒性及微小RNA预测肝毒性的应用
本文报告一例19岁囊性纤维化女性患者,过量服用对乙酰氨基酚10 g后就诊急诊科。对乙酰氨基酚浓度低于列线图线,但因症状在过量后7小时给予乙酰半胱氨酸治疗。尽管早期启动乙酰半胱氨酸,患者在过量后19小时仍发生肝毒性,摄入后6天康复出院。就诊时delta miRNA-122-miR483为对照患者的20倍,而丙氨酸氨基转移酶正常。讨论指出囊性纤维化患者更易存在谷胱甘肽缺乏和肝损伤易感性,delta miRNA可能比肝氨基转移酶更早检测肝损伤,在此情况下应考虑经验性乙酰半胱氨酸治疗和系列生化再评估。
要点
- 囊性纤维化患者对乙酰氨基酚过量后,即使血药浓度低于列线图线且7小时即用乙酰半胱氨酸,仍在19小时发生肝毒性。
- 就诊时delta miRNA-122-miR483为对照患者的20倍,而丙氨酸氨基转移酶正常,提示miRNA可能更早检出肝损伤。
- 囊性纤维化患者更易有谷胱甘肽缺乏和肝损伤易感性,作者认为在此情况下应考虑经验性乙酰半胱氨酸治疗和系列生化再评估。
- 该患者摄入后6天康复出院。
适用人群与场景
- 19岁女性,有囊性纤维化病史,因过量服用对乙酰氨基酚10 g就诊急诊科。
处置流程与药物剂量
- 对乙酰氨基酚浓度低于列线图线,但因患者症状在过量后7小时给予乙酰半胱氨酸治疗。
- 作者认为在此情况下应考虑经验性乙酰半胱氨酸治疗和系列生化再评估。
研究设计与关键结果
- 病例报告:19岁囊性纤维化女性过量服用对乙酰氨基酚10 g,血药浓度低于列线图线,过量后7小时因症状给予乙酰半胱氨酸,19小时后仍发生肝毒性,摄入后6天康复出院。
- 就诊时delta miRNA-122-miR483为对照患者的20倍,而丙氨酸氨基转移酶正常。
证据类型、等级与局限
- 证据类型:病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 囊性纤维化患者对乙酰氨基酚过量后,即使血药浓度低于列线图线且早期使用乙酰半胱氨酸,仍可能发生肝毒性,作者认为应考虑经验性乙酰半胱氨酸治疗和系列生化再评估。
- delta miRNA可能比肝氨基转移酶更早检测肝损伤。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CASE DETAILS: A 19-year-old girl presented to the emergency department following overdose of 10 g of paracetamol on a background history of cystic fibrosis. Paracetamol concentration was below the nomogram line, but was treated with acetylcysteine seven hours post-overdose given her symptomatology. Nineteen hours following her overdose she developed hepatotoxicity, despite early initiation of acetylcysteine. She was discharged well six days post-ingestion. On presentation, delta miRNA-122-miR483 was 20 times that of control patients, however, alanine aminotransferase was normal.
DISCUSSION: Patients with cystic fibrosis are more likely to have glutathione deficiency, and greater susceptibility to liver injury. Delta miRNA may be a better detector of early liver injury than hepatic aminotransferases. Empiric treatment with acetylcysteine and serial biochemical reassessment in this setting should be considered.
参考来源
- Wong A, Cheung B, Nejad C, et al. Hepatotoxicity after paracetamol overdose in a patient with cystic fibrosis despite early acetylcysteine and utility of microRNA to predict hepatotoxicity. Clin Toxicol (Phila). 2018. PMID: 29564929. doi:10.1080/15563650.2018.1454596
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。